Carcinogenicity of antitumor cis-platinum(II) coordination complexes in the mouse and rat.

No abstract is available for this paper.

• Publication year

  1979

• Venue

  Cancer Research

• Publication date

  1979-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 427778
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relative efficiencies of a series of square-planar plantinum(II) compounds on Salmonella mutagenesis.

  1977cited by this paper
• The carcinogenicity of anticancer drugs: A hazard in man

  1976cited by this paper
• Antileukemic properties of organoplatinum complexes.

  1976cited by this paper
• X-ray photoelectron spectroscopy of DNA-Pt complexes. Evidence of O6 (Gua)-N7 (Gua) chelation of DNA with cis- dichlorodiamine platinum(II).

  1975cited by this paper
• Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test.

  1975cited by this paper
• Mutagenic properties of cis-plantinum(II)diammino-dichloride in Escherichia coli.

  1975cited by this paper
• Mutagenic activity of platinum and ruthenium complexes.

  1975cited by this paper
• The chemical and biological effects of cis-dichlorodiammineplatinum (II), an antitumor agent, on DNA.

  1974cited by this paper
• The antitumor agent cis-Pt(NH 3 ) 2 Cl 2 : distribution studies and dose calculations for 193m Pt and 195m Pt.

  1973cited by this paper
• Binding of cis- and trans-dichlorodiammineplatinum(II) to nucleosides. I. Location of the binding sites.

  1973cited by this paper
• New platinum complexes with anti-tumour activity.

  1972cited by this paper
• Cross-linking of Complementary Strands of DNA in Mammalian Cells by Antitumour Platinum Compounds

  1972cited by this paper
• Interaction of cis-dichlorodiammineplatinum (II) with DNA.

  1971cited by this paper
• Antileukaemic and Nephrotoxic Properties of Platinum Compounds

  1971cited by this paper
• Acute toxicologic and pathologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat.

  1971cited by this paper
• The induction of lysogenic strains of Escherichia coli by cis-dichloro-diammineplatinum (II).

  1971cited by this paper
• Growth inhibition of rat mammary carcinoma induced by cis-platinum diamminodichloride-II.

  1971cited by this paper
• Inhibitory effects of anti‐tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in vitro

  1970cited by this paper
• Inhibition of Dunning asc itic leukemia and Walker 256 carcinosarcoma with cis-diamminedichloroplatinum (NSC-119875).

  1970cited by this paper
• The successful regression of large solid sarcoma 180 tumors by platinum compounds.

  1970cited by this paper
• Platinum Compounds: a New Class of Potent Antitumour Agents

  1969cited by this paper
• Separation of square planar complexes by thin layer chromatography.

  1966cited by this paper
• Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode

  1965cited by this paper

• Cisplatyna : dokumentacja proponowanych dopuszczalnych wielkości narażenia zawodowego

  2018cites this paper
• Glyco-decorated tobacco mosaic virus as a vector for cisplatin delivery.

  2017cites this paper
• (Mesenchymal) Stem Cell-Based Therapy in Cisplatin-Induced Acute Kidney Injury Animal Model: Risk of Immunogenicity and Tumorigenicity

  2017cites this paper
• Carcinogenicity of Metal Compounds

  2015cites this paper
• The history, genotoxicity, and carcinogenicity of carbon-based fuels and their emissions. Part 3: diesel and gasoline.

  2015cites this paper
• Impact of cytostatic drugs on the DNA stability of higher plants

  2013cites this paper
• Platinum(II) complexes with steroidal esters of L-methionine and L-histidine: synthesis, characterization and cytotoxic activity.

  2008cites this paper
• Acute nonlymphocytic leukemia following chemotherapy with cisplatin and etoposide for non-small-cell carcinoma of the lung: case report

  2008cites this paper
• Cellular pharmacology, antineoplastic activity and low in vivo toxicity of a carboxylato-bridged platinum(II) complex bis(acetato)diammine-bis-micro-acetato diplatinum (II) dihydrate.

  2007cites this paper
• Point mutation of K-ras gene in cisplatin-induced lung tumours in A/J mice.

  2007cites this paper
• Synthesis and Anchoring of Antineoplastic Ferrocene and Phthalocyanine Derivatives on Water-Soluble Polymeric Drug Carriers Derived from Lysine and Aspartic Acid

  2007cites this paper
• Cisplatin-DNA damage in p21WAF1/Cip1 deficient mouse keratinocytes exposed to cisplatin.

  2006cites this paper
• Hypersusceptibility to cisplatin carcinogenicity in metallothionein‐I/II double knockout mice: Production of hepatocellular carcinoma at clinically relevant doses

  2006cites this paper
• Medicament, orientations en matiere de prise de medicament, systeme de detection magnetique, et procede de mise au point d'un medicament

  2006cites this paper
• Morphological and growth alterations in Vero cells transformed by cisplatin

  2006cites this paper
• Zytotoxische Effekte von Platin(IV)chlorid auf Zellstämme aus Leber- und Nierengewebe

  2006cites this paper
• Zubereitung von Zytostatika in Apotheken: Untersuchungen zur Arbeitsplatzkontamination

  2006cites this paper
• Platinum group elements in the environment and their health risk.

  2004cites this paper
• Cancer risk from inorganics

  2004cites this paper
• Rapid onset of acute myeloid leukaemia following radiotherapy and chemotherapy for metastatic seminoma of the testis

  2004cites this paper
• Synthesis, characterization and mutagenicity of new cis-[Pt(2-substituted-benzimidazole)2Cl2] complexes.

  2003cites this paper
• DNA damage and repair in human lymphocytes exposed to three anticancer platinum drugs.

  2000cites this paper
• The role of DNA mismatch repair in cisplatin mutagenicity.

  1999cites this paper
• Scientific Basis for Swedish Occupational Standards XVIII

  1997cites this paper
• Perinatal Effects of Metals and Cancer in Offspring

  1997cites this paper
• Genotoxicity of platinum and palladium compounds in human and bacterial cells.

  1997cites this paper
• Elevated mitochondrial cisplatin-DNA adduct levels in rat tissues after transplacental cisplatin exposure.

  1997cites this paper
• Cisplatin-DNA adduct formation in maternal and fetal rat tissues after transplacental cisplatin exposure.

  1996cites this paper
• Down-regulation of metallothionein expression in human and murine hepatocellular tumors: association with the tumor-necrotizing and antineoplastic effects of cadmium in mice.

  1996cites this paper
• Effect of quercetin on the genotoxic potential of cisplatin

  1996cites this paper
• Cyto- and genotoxic effects of coordination complexes of platinum, palladium and rhodium in vitro

  1996cites this paper
• Transplacental carcinogenesis by cisplatin in F344/NCr rats: promotion of kidney tumors by postnatal administration of sodium barbital.

  1995cites this paper
• Does determination of tissue platinum levels by mass spectroscopy have potential for monitoring exposure of pharmacy personnel to platinum-based antineoplastic drugs? A pilot study

  1995cites this paper
• Comparative Toxicities and Mutagenicities of Platinum Anticancer Drugs*

  1995cites this paper
• DNA adducts in human and patas monkey maternal and fetal tissues induced by platinum drug chemotherapy.

  1994cites this paper
• Urinary platinum in hospital personnel occupationally exposed to platinum-containing antineoplastic drugs

  1994cites this paper
• Effects of DNA adduct structure and distribution on the mutagenicity and genotoxicity of two platinum anticancer drugs.

  1994cites this paper
• Interactions in metal carcinogenicity.

  1994cites this paper
• Genotoxic effects of metal compounds.

  1994cites this paper
• Secondary myelodysplasia and acute leukemia following carboplatin-containing combination chemotherapy for ovarian cancer.

  1993cites this paper
• Transplacental carcinogenicity of cisplatin: initiation of skin tumors and induction of other preneoplastic and neoplastic lesions in SENCAR mice.

  1993cites this paper
• Acute leukemia associated with mediastinal germ cell tumor. De novo versus therapy-related leukemia.

  1993cites this paper
• Cisplatin enhances the metastatic potential of human colon carcinoma

  1993cites this paper
• Further evidence of the tumor-suppressive effects of cadmium in the B6C3F1 mouse liver and lung: late stage vulnerability of tumors to cadmium and the role of metallothionein.

  1993cites this paper
• Prevention of carcinogenicity of anticancer drugs by metallothionein induction.

  1993cites this paper
• Molecular Aspects of Platinum-DNA Interactions

  1993cites this paper
• Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients.

  1992cites this paper
• Is cisplatin a human carcinogen?

  1992cites this paper
• Mutations recovered in the Chinese hamster aprt gene after exposure to carboplatin: a comparison with cisplatin.

  1992cites this paper
• Analysis of the Harvey ras gene in cisplatin-initiated mouse skin tumors by polymerase chain reaction and direct DNA sequencing.

  1992cites this paper
• In vitro mutational specificity of cisplatin in the human hypoxanthine guanine phosphoribosyltransferase gene.

  1992cites this paper
• Platinum in the human diet, blood, hair and excreta.

  1992cites this paper
• Randomized trial comparing cisplatin with radioactive phosphorus or whole‐abdomen irradiation as adjuvant treatment of Ovarian cancer

  1992cites this paper
• Spectrum of cis‐diamminedichloroplatinum(II)‐induced mutations in a shuttle vector propagated in human cells

  1991cites this paper
• Cancer chemotherapy involving platinum and other platinum group complexes.

  1991cites this paper
• Carcinogenic properties of pharmaceutical agents evaluated in the IARC Monographs programme.

  1991cites this paper
• The Role of Non-Platinum Complexes in Cancer Therapy

  1990cites this paper
• Enhanced malignant conversion of benign mouse skin tumors by cisplatin.

  1990cites this paper
• Measurement of DNA adducts by immunoassays.

  1990cites this paper
• Acute leukemia following cisplatin-based chemotherapy in a patient with ovarian cancer.

  1990cites this paper
• Platinum (II) Polyamines: Relationship of Chain Length to Biological Activity

  1990cites this paper
• Metal Complexes as Antitumour Agents

  1990cites this paper
• Protein binding, sister chromatid exchange and expression of oncogene proteins in patients treated with cisplatinum (cisDDP)-based chemotherapy

  1990cites this paper
• Sequence specificity of mutation induced by the anti-tumor drug cisplatin in the CHO aprt gene.

  1989cites this paper
• Clastogenic effects of cis-diamminedichloroplatinum. I. Induction of chromosomal aberrations in somatic and germinal cells of mice.

  1989cites this paper
• Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancer

  1989cites this paper
• Chemical and biological studies of the major DNA adduct of cis-diamminedichloroplatinum(II), cis-[Pt(NH3)2(d(GpG]], built into a specific site in a viral genome.

  1988cites this paper
• Long-term complications of cisplatin-based chemotherapy for testis cancer.

  1988cites this paper
• DNA adducts of cisplatin in nucleated peripheral blood cells and tissues of cancer patients.

  1987cites this paper
• Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy.

  1987cites this paper
• Spectrum of cisplatin-induced mutations in Escherichia coli.

  1987cites this paper
• Micronucleus test in bone marrow of mice treated with 1-nitropropane, 2-nitropropane and cisplatin.

  1987cites this paper
• Genotoxic effects of cisplatin in somatic tissue of Drosophila melanogaster

  1987cites this paper
• Chemotherapy-induced malignancies in rats after treatment with cisplatin as single agent and in combination: preliminary results.

  1986cites this paper
• Charles F. Kettring prize. Fundamental studies with cisplatin

  1985cites this paper
• Carcinogenicity Testing of Antitumor Agents

  1985cites this paper
• Metabolism of chemical carcinogens.

  1985cites this paper
• Cisplatin as an initiating agent in two-stage mouse skin carcinogenesis.

  1985cites this paper
• Genotoxic classification of anticancer drugs.

  1985cites this paper
• Fundamental studies with cisplatin.

  1985cites this paper
• Recent advances in metal carcinogenesis.

  1984cites this paper
• Bladder cancer induced by noncarcinogenic substances.

  1984cites this paper
• Diaminocyclohexane(isocitrato)platinum(ll)1

  1984cites this paper
• cis-Diamminedichloroplatinum(II): effects of a representative metal coordination complex on mammalian cells.

  1984cites this paper
• Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II).

  1984cites this paper
• Relationships between functionality and genetic toxicology of selected DNA-damaging agents.

  1984cites this paper
• Mechanisms of cisplatin (cis-diamminodichloroplatinum II)-induced cytotoxicity and genotoxicity in yeast.

  1984cites this paper
• Effects of Cisplatin, Bleomycin and DTIC on Immune Function in vitro and in vivo

  1984cites this paper
• Acute leukemia following therapy for teratoma.

  1984cites this paper
• Uptake and metabolism of cisplatin by rat kidney.

  1984cites this paper
• Embryotoxicity of cisplatin in rats and mice.

  1983cites this paper
• A study of biocides for the selection of candidates for carcinogen bioassay

  1983cites this paper
• Action of Platinum Antitumour Drugs

  1983cites this paper
• Mutagenic activity and identification of excreted platinum in human and rat urine and rat plasma after administration of cisplatin.

  1983cites this paper
• Teratogenic action of platinum thymine blue.

  1982cites this paper
• Exposure of pharmacy personnel to mutagenic antineoplastic drugs.

  1982cites this paper
• Prophage induction and mutagenicity of a series of anti-tumour platinum(II) and platinum(IV) co-ordination complexes.

  1982cites this paper
• The effect of cis-diamminedichloroplatinum (II) on immune function in vitro and in vivo

  1982cites this paper
• New toxicology: Carcinogenesis I

  1982cites this paper
• New toxicology: Carcinogenesis III

  1982cites this paper